Company / SG&A per Share
ENvue Medical, Inc. SG&A per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest SG&A per Share
$91.33
FY2025
5-year range
$0.19 / $91.33
FY2021-FY2025
Trend
+333.0%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
SG&A per Share changed +333% YoY in FY2025, a notable deviation from the 9-year average annual change of +328%.
Based on SEC 10-K filings.
91.33 in FY2025 with a 5-year CAGR of +151.4%.
Increased from $2.40 to $91.33 over the past 2 years.
SG&A per Share over time
Growth rates
- 3-Year CAGR
- +193.5%
- 5-Year CAGR
- +151.4%
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, sg&a per share increased 333.0% year-over-year.
- Lowest sg&a per share in the period was in FY2021.
Company context
Key Data Points
- Altman Z-Score -0.19 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | SG&A per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $91.33 | +333.0% |
| FY2024 | $21.09 | +780.6% |
| FY2023 | $2.40 | -33.7% |
| FY2022 | $3.61 | +1803.3% |
| FY2021 | $0.19 | -79.1% |
| FY2020 | $0.91 | +31.1% |
| FY2019 | $0.69 | +31.0% |
| FY2018 | $0.53 | +2.6% |
| FY2017 | $0.52 | +80.7% |
| FY2016 | $0.29 | -92.1% |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026